Mazur Leonard L 4

Accession 0001013762-23-003528

CIK 0001506251other

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 4:15 PM ET

Size

21.7 KB

Accession

0001013762-23-003528

Form 4

Period: 2023-10-10

DirectorChief Executive Officer

Transactions

Award
Option to Purchase Common Stock
2023-10-10+550,000→ 550,000 total
Exercise: $0.70Exp: 2033-10-10→ Common Stock (550,000 underlying)

Holdings

Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (40,000 underlying)
40,000
Warrant to Purchase Common Stock
Exercise: $1.42Exp: 2024-04-05→ Common Stock (1,165,048 underlying)
1,165,048
Common Stock
10,255,343
Options to Purchase Common Stock
Exercise: $2.00Exp: 2031-07-22→ Common Stock (300,000 underlying)
300,000
Option to Purchase Common Stock
Exercise: $1.25Exp: 2032-10-04→ Common Stock (550,000 underlying)
550,000
Options to Purchase Common Stock
Exercise: $1.01Exp: 2030-10-06→ Common Stock (200,000 underlying)
200,000
Option to Purchase Common Stock
Exercise: $2.04Exp: 2031-10-11→ Common Stock (650,000 underlying)
650,000
Options to Purchase Common Stock
Exercise: $1.62Exp: 2028-09-04→ Common Stock (150,000 underlying)
150,000
Options to Purchase Common Stock
Exercise: $0.67Exp: 2029-10-08→ Common Stock (175,000 underlying)
175,000
Options to Purchase Common Stock
Exercise: $6.75Exp: 2024-09-12→ Common Stock (220,000 underlying)
220,000
Warrant to Purchase Common Stock
Exercise: $1.15Exp: 2024-08-14→ Common Stock (3,137,255 underlying)
3,137,255
Warrant to Purchase Common Stock
Exercise: $0.77Exp: 2024-09-27→ Common Stock (2,234,700 underlying)
2,234,700

Footnotes (10)

[F1]The options vested in full on September 13, 2020.
[F10]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
[F2]The options vested in full on September 12, 2017
[F3]The warrant is fully vested and exercisable immediately.
[F4]The options vested in full on September 4, 2021.
[F5]The options vested in full on October 8, 2022.
[F6]The options vested in full on October 6, 2023.
[F7]The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
[F8]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
[F9]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

Documents

1 file

Citius Pharmaceuticals, Inc.

CIK 0001506251

Entity typeother